A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumumab, Lenalidomide and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Transplant Ineligible
Hellenic Society of Hematology
Hellenic Society of Hematology
Celularity Incorporated
Hellenic Society of Hematology
Hellenic Society of Hematology
University of Erlangen-Nürnberg Medical School
National Cancer Institute (NCI)
National Cancer Institute (NCI)